Congratulations to Mark from the Department of Microbiology and Immunology and Dr. Erin Gaynor. Mark defended his thesis titlted "Campylobacter jejuni metabolism in Survival and Host Cell Interactions". Marc is continuing his academic career by taking a Pharmacology degree.
Congratulations to Dr. Bob Hancock, whose Tier 1 CRC in “New Anti-infective Strategies” has been renewed for another 7-year term. Dr. Hancock and his team are working to develop alternative drugs and methods to fight life-threatening superbugs that exhibit antibiotic resistance.
Congratulations to Dr. Lindsay Eltis, who has been named a Tier 1 CRC in "Microbial Catabolism and Biocatalysis". Lindsay's research aims to increase our understanding bacterial pathways and enzymes involved in the catabolism of aromatic compounds and steroids. His research is contributing to the development of powerful new biocatalysts to transform biomass as well as to the development of novel therapeutics for tuberculosis.
The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4+ T cells Nat Immunol. 2014 Oct 5. doi: 10.1038/ni.3009. http://www.nature.com/ni/journal/vaop/ncurrent/full/ni.3009.html Samuel Bertin1, Yukari Aoki-Nonaka1,2, Petrus Rudolf de Jong1, Lilian L Nohara3,8, Hongjian Xu3,8, Shawna R Stanwood3, Sonal Srikanth4, Jihyung Lee1, Keith To1, Lior Abramson1, Timothy Yu1, Tiffany Han1, Ranim Touma5, Xiangli Li1, José M González-Navajas1, Scott Herdman1, Maripat Corr1, Guo Fu6,7, Hui Dong1, Yousang Gwack4, Alessandra Franco5, Wilfred A... Read More
Congratulations to Dr. Brett Finlay on receiving the 2014 Prix Galien Canada award. The following is the citation from the organization's webpage: "The Prix Galien is the most prestigious award in the field of Canadian pharmaceutical research and innovation. Referred to as the Nobel Prize of pharmaceutical research, it recognizes the efforts and achievements of pharmaceutical research and development." Congrats!